33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM)
    Meeting Abstract

    Hari, P.; Pasquini, M. C.; Stadtmauer, E. A.; Fraser, R.; Fei, M.; Devine, S. M.; Efebera, Y. A.; Geller, N.; Horowitz, M. M.; Koreth, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT)
    Meeting Abstract

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Silagy, A. W.; Marker, M.; Reising, A.; Millholland, J.; Chan, T. A. T.; Russo, P.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results
    Meeting Abstract

    Gutierrez, M.; Long, G. V.; Friedman, C. F.; Richards, D. A.; Corr, B.; Bastos, B. R.; Uemura, M. I.; Conkling, P. R.; Moreno, V.; Edenfield, W. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The first report of pediatric patients with solid tumors treated with venetoclax
    Meeting Abstract

    Goldsmith, K. C.; Verschuur, A.; Morgenstern, D. A.; van Eijkelenburg, N.; Federico, S. M.; Fraser, C.; Forlenza, C. J.; Ziegler, D. S.; Gerber, N. U.; Khaw, S. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy, safety, and immune priming effect of tazemetostat in patients with epithelioid sarcoma
    Meeting Abstract

    Gounder, M. M.; Stacchiotti, S.; Schoffski, P.; Cote, G. M.; Villalobos, V. M.; Jahan, T. M.; Chen, T. W. W.; Ratan, R.; Gupta, A. A.; Dileo, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer
    Meeting Abstract

    Goto, K.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T. M.; Gainor, J. F.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Checkpoint inhibitor treatment-related cutaneous adverse events in skin of color patients at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Geisler, A.; Barrios, D. M.; Noor, S. J.; Lacouture, M. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
    Meeting Abstract

    George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save